Biodegradable polymeric nanoparticles based drug delivery systems
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Biodegradable nanoparticles have been used frequently as drug delivery vehicles due to its grand bioavailability, better encapsulation, control release and less toxic properties. Various nanoparticulate systems, general synthesis and encapsulation process, control release and improvement of therapeutic value of nanoencapsulated drugs are covered in this review. We have highlighted the impact of nanoencapsulation of various disease related drugs on biodegradable nanoparticles such as PLGA, PLA, chitosan, gelatin, polycaprolactone and poly-alkyl-cyanoacrylates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Encyclopedia of Nanoscience and Nanotechnology
(2013) · Chemical & Engineering News Archive · doi:10.1021/cen-09136-ad11 · Cited by 2,546
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Cited by
Items 101–147 of 147
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Bruni, N., Della Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018) · Molecules · doi:10.3390/molecules23102478 · Cited by 272
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Zhang, C., Wan, X., Zheng, X., Shao, X., Liu, Q., Zhang, Q., & Qian, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.063 · Cited by 262
Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles
Sulheim, E., Baghirov, H., von Haartman, E., Bøe, A., Åslund, A. K. O., Mørch, Y., & Davies, C. D. L. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0156-7 · Cited by 262
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
Mody, K. T., Popat, A., Mahony, D., Cavallaro, A. S., Yu, C., & Mitter, N. (2013) · Nanoscale · doi:10.1039/c3nr00357d · Cited by 261
Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus
Yang, M., Lai, S. K., Wang, Y., Zhong, W., Happe, C., Zhang, M., Fu, J., & Hanes, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006849 · Cited by 260
Amoabediny, G., Haghiralsadat, F., Naderinezhad, S., Helder, M. N., Akhoundi Kharanaghi, E., Mohammadnejad Arough, J., & Zandieh-Doulabi, B. (2018) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2017.1332623 · Cited by 256
Martínez-Ballesta, M., Gil-Izquierdo, Á., García-Viguera, C., & Domínguez-Perles, R. (2018) · Foods · doi:10.3390/foods7050072 · Cited by 256
Protein‐Based Delivery Systems for the Nanoencapsulation of Food Ingredients
Fathi, M., Donsi, F., & McClements, D. J. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12360 · Cited by 254
Huda, M. N., Nafiujjaman, M., Deaguero, I. G., Okonkwo, J., Hill, M. L., Kim, T., & Nurunnabi, M. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00217 · Cited by 254
Vitamin E-based nanomedicines for anti-cancer drug delivery
Duhem, N., Danhier, F., & Préat, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.009 · Cited by 253
Drug delivery vehicles on a nano-engineering perspective
Felice, B., Prabhakaran, M. P., Rodríguez, A. P., & Ramakrishna, S. (2014) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.04.049 · Cited by 253
Recent progress on nanoparticle-based drug delivery systems for cancer therapy
Xin, Y., Yin, M., Zhao, L., Meng, F., & Luo, L. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2017.0052 · Cited by 250
Chen, T., Yang, Tang, Zhong, Bai, Zhang, Li, & Zheng (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28278 · Cited by 243
Nanoparticle formulations of cisplatin for cancer therapy
Duan, X., He, C., Kron, S. J., & Lin, W. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1390 · Cited by 216
PLGA based drug delivery systems: promising carriers for wound healing activity
Chereddy, K. K., Vandermeulen, G., & Préat, V. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12404 · Cited by 215
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181
Drug Delivery with polymeric nanocarriers-cellular uptake mechanisms
Nelemans, L. C., & Gurevich, L. (2020) · Materials · doi:10.3390/ma13020366 · Cited by 173
Abd Ellah, N. H., & Abouelmagd, S. A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1213238 · Cited by 164
Li, F., Mei, H., Gao, Y., Xie, X., Nie, H., Li, T., Zhang, H., & Jia, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.030 · Cited by 152
Serrano-Sevilla, I., Artiga, Á., Mitchell, S. G., De Matteis, L., & de la Fuente, J. M. (2019) · Molecules · doi:10.3390/molecules24142570 · Cited by 148
Cano, A., Sánchez-López, E., Ettcheto, M., López-Machado, A., Espina, M., Souto, E. B., Galindo, R., Camins, A., García, M. L., & Turowski, P. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0443 · Cited by 144
PEGylated nanomedicines: recent progress and remaining concerns
Vllasaliu, D., Fowler, R., & Stolnik, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866651 · Cited by 137
Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles
Sharma, D., Sharma, R. K., Sharma, N., Gabrani, R., Sharma, S. K., Ali, J., & Dang, S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0294-0 · Cited by 127
Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122
“Polymeric‐based nanoparticles for Alzheimer’s disease Due to their versatility and ease of fabrication by different methods, polymeric NPs (PNPs) are among the most used carriers in nanomedicine applications [168, 169].”
BackgroundSorasitthiyanukarn, F. N., Muangnoi, C., Rojsitthisak, P., & Rojsitthisak, P. (2022) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2021.107246 · Cited by 115
Zhang, B., Yan, W., Zhu, Y., Yang, W., Le, W., Chen, B., Zhu, R., & Cheng, L. (2018) · Advanced Materials · doi:10.1002/adma.201705694 · Cited by 113
The potential of magneto-electric nanocarriers for drug delivery
Kaushik, A., Jayant, R. D., Sagar, V., & Nair, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.933803 · Cited by 113
“Figure 1 summarizes the types of NCs, for example, polymers [14-26], metal--metal oxide NPs [27-32], core--shell NPs [33], quantum dots NPs [34-36], hybrid nanocomposites [33,37], organic--inorganic frameworks [38-40] and novel structures like microneedles [41].”
Jusu, S. M., Obayemi, J. D., Salifu, A. A., Nwazojie, C. C., Uzonwanne, V., Odusanya, O. S., & Soboyejo, W. O. (2020) · Scientific Reports · doi:10.1038/s41598-020-71129-0 · Cited by 112
Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles
Kheiri Manjili, H., Ghasemi, P., Malvandi, H., Mousavi, M. S., Attari, E., & Danafar, H. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.003 · Cited by 108
Yang, H. Y., Li, Y., & Lee, D. S. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800011 · Cited by 107
Jia, C., Chen, H., Wei, M., Chen, X., Zhang, Y., Cao, L., Yuan, P., Wang, F., Yang, G., & Ma, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s138400 · Cited by 106
“36–38 It is thus interesting to test whether PLGA-or chitosan-based nanoparticles would produce similar and even better beneficial results.”
Clinical therapies and nano drug delivery systems for urinary bladder cancer
Jain, P., Kathuria, H., & Momin, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107871 · Cited by 89
Davoudi, Z., Peroutka-Bigus, N., Bellaire, B., Jergens, A., Wannemuehler, M., & Wang, Q. (2021) · Marine Drugs · doi:10.3390/md19050282 · Cited by 84
Yusuf, M., Khan, M., Alrobaian, M. M., Alghamdi, S. A., Warsi, M. H., Sultana, S., & Khan, R. A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102214 · Cited by 72
Development of Mesoporous Silica Nanomaterials As a Vehicle for Anticancer Drug Delivery
Yanes, R. E., & Tamanoi, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.9 · Cited by 68
Del Amo, L., Cano, A., Ettcheto, M., Souto, E. B., Espina, M., Camins, A., García, M. L., & Sánchez-López, E. (2021) · Applied Sciences · doi:10.3390/app11094305 · Cited by 67
“Hydrolysis of PLGA NPs (based on [5]).”
BackgroundLuiz, M. T., Abriata, J. P., Raspantini, G. L., Tofani, L. B., Fumagalli, F., de Melo, S. M. G., Emery, F. D. S., Swiech, K., Marcato, P. D., Lee, R., et al. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110038 · Cited by 63
New Vision for Visual Prostheses
Farnum, A., & Pelled, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00036 · Cited by 58
“Nanoparticles are extensively utilized in the fields of drug delivery (Kumari et al., 2010), biosensing (Doria et al.”
BackgroundLien, C.-F., Molnár, É., Toman, P., Tsibouklis, J., Pilkington, G. J., Górecki, D. C., & Barbu, E. (2012) · Biomacromolecules · doi:10.1021/bm201790s · Cited by 42
Ghumman, S. A., Bashir, S., Noreen, S., Khan, A. M., & Malik, M. Z. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.100 · Cited by 39
Chen, G., Svirskis, D., Lu, W., Ying, M., Li, H., Liu, M., & Wen, J. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118592 · Cited by 36
Nardo, T., Chiono, V., Gentile, P., Tabrizian, M., & Ciardelli, G. (2016) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2016.1163566 · Cited by 11
Xu, J.-F., Wang, Y.-P., & Liu, X.-H. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.06.019 · Cited by 12
History, introduction, and properties of PLGA as a drug delivery carrier
Yurtdaş Kırımlıoğlu, G. (2023) · Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery · doi:10.1016/b978-0-323-91215-0.00001-7 · Cited by 9
Naolou, T., Lendlein, A., & Neffe, A. T. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00346 · Cited by 5
Metadata
- Authors
- Kumari, A., Yadav, S. K., & Yadav, S. C.
- Venue
- Colloids and Surfaces B: Biointerfaces
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 75
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0927-7765 (ISSN-L)
- OpenAlex
- W2066685510
- Cited by
- 3,724
- References
- 121
- FWCI
- 35.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.